Answers are grounded in this paper and cite their sources.
Even if chemotherapy is the cornerstone treatment of small cell lung cancer (SCLC), this disease has a particular propensity to recur locally and disseminate in the brain. Hence, there have been several randomized trials assessing the role of thoracic and brain radiotherapy (1). Two individual patient data-based meta-analyses showed that thoracic radiotherapy and prophylactic cranial irradiation (PCI) should be part of the therapeutic strategy (2,3).
No takes yet. Share an insight, caveat, or question.
Péchoux et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: